Percutaneous Extracorporeal Ventricular Assist Device as a Successful Bridge Strategy to Durable Left Ventricular Assist Device in Refractory Cardiogenic Shock: A Case Report - Takeaways - MDSpire

Percutaneous Extracorporeal Ventricular Assist Device as a Successful Bridge Strategy to Durable Left Ventricular Assist Device in Refractory Cardiogenic Shock: A Case Report

  • By

  • Li, Dan

  • Chen, Jianfeng

  • Liu, Jinping

  • Zhao, Jinping

  • April 27, 2026

  • 0 min

Share

  • 1

    Cardiogenic shock is a critical condition with high mortality, necessitating temporary mechanical circulatory support for stabilization.

  • 2

    Traditional devices like IABP and ECMO have limitations, while advanced options like Impella are not widely accessible in some regions.

  • 3

    A 39-year-old male with refractory cardiogenic shock was treated with a percutaneous extracorporeal VAD due to unstable hemodynamics.

  • 4

    The extracorporeal VAD procedure was complication-free and led to significant patient improvement, allowing for durable LVAD implantation.

  • 5

    This case highlights the effectiveness of minimally invasive VADs as a bridge-to-bridge therapy in managing severe cardiogenic shock.

Original Source(s)

Percutaneous Extracorporeal Ventricular Assist Device as a Successful Bridge Strategy to Durable Left Ventricular Assist Device in Refractory Cardiogenic Shock: A Case Report

  • by Li, Dan , Chen, Jianfeng , Liu, Jinping , Zhao, Jinping

  • April 27, 2026

Related Content

Heart failure risk prediction based on machine learning and interpretability analysis

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Independent prognostic value of the triglyceride–glucose index and its incremental predictive contribution beyond traditional risk markers in acute heart failure: a retrospective cohort study